Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

14 Aug 2009 07:00

RNS Number : 4266X
Creston PLC
14 August 2009
 



Press Release  14 August 2009

Creston plc 

Interim Management Statement 

Creston plc (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2009 to 30 July 2009.

Trading

The Group's trading overall remains in line with management's expectations. After a robust performance in our last financial year, which saw like-for-like revenue growth in each quarter and 4 per cent for the full year, the prevailing economic recession has caused an anticipated decline and re-phasing of marketing budgets for some clients during the first quarter of the new financial year. The Group has reported a like-for-like revenue decline of 6 per cent for the first quarter compared with the particularly strong first quarter growth of 5 per cent last year. 

The Insight Division had its highest level of secured commissions by this point in the year. The Communications Division has been effected by the expected client budget cuts, however, this has been partly offset by the new business wins from last year. The Health Division's growth has been driven by the new medical education and international offers and their continuing excellent performance in new business.

Although the current economic climate is having an effect on client budgets, we continue to win new business to offset the impact. New business wins to date include Astellas, Astra Zeneca, BMW Motorrad, COI (blood and transplant and vulnerable workers), E-on, GSK and Saudi Arabian General Investment Authority plus other major wins yet to be announced. The new business pipeline remains strong and with a historical high pitch to win ratio, we are confident of winning a good proportion of the opportunities. 

Balance Sheet

On 7 July 2009 the Company successfully raised £3.3m (gross) through a limited capital raising from long term shareholders. The fundraising provides additional working capital for the Group, and also allows for investment in our organic growth plans in areas such as mobile and digital healthcare marketing.

The Group continues to manage its working capital effectively and has generated operating cash flow in line with the Board's expectations. 

Outlook

Despite the current economic climate we believe that the Group's new divisional structure and the new business pipeline stand the Group in good stead for the full year. 

For further information, please contact:

Creston plc

020 7930 9757

Don Elgie, Chief Executive

Barrie Brien, COO/CFO

www.creston.com 

Hogarth Partnership Limited

020 7357 9477

Chris Matthews/Fiona Noblet/Anthony Arthur

 

About Creston plc

Creston is an Insight and Communications company for the 21st century. It offers clients more seamless access to the most innovative marketing insights and communications services to help grow their brands in a rapidly-changing consumer world. Our companies draw upon the collective knowledge, expertise and services from across-the-Group, so that their clients receive the best advice and achieve the best results no matter what the medium. By working together, whether on research or as full-scale marketing partners, our companies continuously innovate to make more things possible for their clients and people.

Creston companies offer a range of marketing services, such as advertising, direct and digital marketing, market research, public relations and healthcare marketing to a broad range of blue-chip clients including: Amazon, AstraZeneca, Aviva, Bayer, BMW, BT, Burger King, Canon, COI Communications, Cow & Gate, Daily Mirror, Diageo, E-on, First Direct, GlaxoSmithKline, Halifax, Homeform, House of Fraser, Kimberly-Clark, Lexus, Lloyds Black Horse, Morrisons, NHS Lottery, Nissan, Opel, Pfizer, Roche Diagnostics, Royal Mail, SAB Miller, Sainsbury's, Tesco, Thorpe Park, Toshiba, Trinity Mirror, T-Mobile, Tropicana, Unilever, Vauxhall, Vodafone, Walkers and WH Smith.

Creston's share price is quoted in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAKPDFEXNEFE
Date   Source Headline
16th May 20254:48 pmRNSDirector/PDMR Shareholding
14th May 20255:57 pmRNSResult of AGM
14th May 20255:51 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSCEO appointment and Directorate Changes
14th May 20257:00 amRNSTrading Update for Q1 2025
6th May 20257:00 amRNSNotice of Q1 2025 Trading Update
22nd Apr 20257:00 amRNSAppointment of Interim CUO
10th Apr 20255:07 pmRNSNotice of AGM
10th Apr 20254:40 pmRNSHolding(s) in Company
10th Apr 20254:39 pmRNSPurchase of Shares by Employee Benefit Trust
9th Apr 20255:49 pmRNSDirector/PDMR Shareholding
9th Apr 20255:33 pmRNSPurchase of Shares by Employee Benefit Trust
8th Apr 20252:59 pmRNSPurchase of Shares by Employee Benefit Trust
7th Apr 20251:28 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20255:27 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20251:21 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:22 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:08 pmRNSPurchase of Shares by Employee Benefit Trust
2nd Apr 20255:10 pmRNSHolding(s) in Company
2nd Apr 20255:09 pmRNSPurchase of Shares by Employee Benefit Trust
1st Apr 20256:20 pmRNSDirector/PDMR Shareholding
31st Mar 20257:00 amRNSCEO Retirement
26th Mar 20255:54 pmRNSDirector/PDMR Shareholding
26th Mar 20255:51 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:45 pmRNSDirector/PDMR Shareholding
26th Mar 20255:44 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
14th Mar 202512:20 pmRNSNotification of Major Holdings
14th Mar 202512:19 pmRNSNotification of Major Holdings
11th Mar 202512:22 pmRNSNotification of Major Holdings
27th Feb 20258:00 amRNSPublication of 2024 Annual Report and Accounts
25th Feb 20257:00 amRNSDirector/PDMR Shareholding
24th Feb 20257:00 amRNSDirector/PDMR Shareholding
19th Feb 20257:00 amRNSPreliminary results for the year ended 31/12/24
30th Jan 20257:00 amRNSNotice of Results
18th Dec 20247:00 amRNSComment on AM Best ratings outlook
15th Nov 20247:00 amRNSDirector/PDMR Shareholding
13th Nov 20245:35 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20247:00 amRNSDirector/PDMR Shareholding - Amendment
7th Nov 20244:26 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSTrading Statement
23rd Oct 20243:02 pmRNSNotice of Results
4th Sep 20243:36 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSInterim Results for the six months to 30/06/2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.